These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32187687)

  • 21. Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: an epidemiologic model-based study.
    Pillonel J; Brandel JP; Léon L; Salomon D; Haïk S; Capek I; Vaillant V; Coste J; Alpérovitch A
    Transfusion; 2012 Jun; 52(6):1290-5. PubMed ID: 22128904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creutzfeldt-Jakob disease and blood transfusion.
    Esmonde TF; Will RG; Slattery JM; Knight R; Harries-Jones R; de Silva R; Matthews WB
    Lancet; 1993 Jan; 341(8839):205-7. PubMed ID: 8093499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant Creutzfeldt-Jakob disease.
    Ironside JW
    Haemophilia; 2010 Jul; 16 Suppl 5():175-80. PubMed ID: 20590878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008.
    Hamaguchi T; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Yamada M
    Emerg Infect Dis; 2009 Feb; 15(2):265-71. PubMed ID: 19193271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creutzfeldt-Jakob disease in recipients of corneal transplants.
    Maddox RA; Belay ED; Curns AT; Zou WQ; Nowicki S; Lembach RG; Geschwind MD; Haman A; Shinozaki N; Nakamura Y; Borer MJ; Schonberger LB
    Cornea; 2008 Aug; 27(7):851-4. PubMed ID: 18650677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there evidence of vertical transmission of variant Creutzfeldt-Jakob disease?
    Murray K; Peters J; Stellitano L; Winstone AM; Verity C; Will RG
    J Neurol Neurosurg Psychiatry; 2011 Jul; 82(7):729-31. PubMed ID: 19401289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prions and transfusion medicine.
    Budka H
    Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom.
    Urwin P; Thanigaikumar K; Ironside JW; Molesworth A; Knight RS; Hewitt PE; Llewelyn C; Mackenzie J; Will RG
    Emerg Infect Dis; 2017 Jun; 23(6):893-7. PubMed ID: 28516863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. vCJD screening and its implications for transfusion--strategies for the future?
    Turner ML
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S65-8. PubMed ID: 14567540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant Creutzfeldt-Jakob disease and blood transfusion.
    Turner ML
    Curr Opin Hematol; 2001 Nov; 8(6):372-9. PubMed ID: 11604578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation.
    Armitage WJ; Tullo AB; Ironside JW
    Eye (Lond); 2009 Oct; 23(10):1926-30. PubMed ID: 19136921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.
    Wroe SJ; Pal S; Siddique D; Hyare H; Macfarlane R; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Hewitt P; Collinge J
    Lancet; 2006 Dec; 368(9552):2061-7. PubMed ID: 17161728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks.
    Pozzo di Borgo A; Rochette S; Gaussen A; O'Brien SF; Germain M; Renaud C; Lewin A
    Transfus Med Rev; 2023 Jul; 37(3):150747. PubMed ID: 37827587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion.
    Turner ML; Ironside JW
    Blood Rev; 1998 Dec; 12(4):255-68. PubMed ID: 9950096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease.
    Sánchez-Juan P; Bishop MT; Green A; Giannattasio C; Arias-Vasquez A; Poleggi A; Knight RS; van Duijn CM
    BMC Med Genet; 2007 Dec; 8():77. PubMed ID: 18072964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.
    Gillies M; Chohan G; Llewelyn CA; MacKenzie J; Ward HJ; Hewitt PE; Will RG
    Vox Sang; 2009 Oct; 97(3):211-8. PubMed ID: 19671123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creutzfeldt-Jakob disease and the risk from blood or blood products.
    Will RG; Kimberlin RH
    Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.